Business
ART to Be Present at the Annual Conference of the American Association for Cancer Research (AACR) in Anaheim, California
ART to Be Present at the Annual Conference of the American Association for Cancer Research (AACR) in Anaheim, California.
About this update from Omai Gold Mines Corp.
[{"type":"text","content":"\n\n\n\n\nMONTREAL, April 14 /CNW Telbec/ - ART Advanced Research Technologies Inc.\n(\"ART\") (TSX: ARA), a leader in optical molecular imaging products for the\nhealthcare and pharmaceutical industries, is pleased to announce its\nparticipation at the annual conference of the American Association for Cancer\nResearch (AACR) being held at the Anaheim Convention Center in Anaheim,\nCalifornia, from April 16 to 20, 2005.\nART will showcase the multiwavelength eXplore Optix(TM) system, a \npre-clinical optical molecular imager designed to provide in vivo\nbiodistribution and pharmacokinetics data, at the GE Healthcare booth\n(No. 787) located in the Exhibit Hall C and D of the Anaheim Convention\nCenter.\n\nAbout AACR\n\nFounded in 1907, AACR's mission is to accelerate the prevention and cure\nof cancer through research, education, communication and advocacy. AACR's\nannual meeting attracts more than 12,000 participants who share new and\nsignificant discoveries in the cancer field.\n\nAbout ART\n\nART Advanced Research Technologies Inc. is a leader in optical molecular\nimaging products for the healthcare and pharmaceutical industries. ART has\ndeveloped two products based on its innovative technology. The first is\neXplore Optix(TM), a molecular imaging device designed for monitoring\nphysiological changes in living systems at the preclinical study phases of new\ndrugs. eXplore Optix(TM) is distributed by GE Healthcare and is used by\nindustry and academic leaders worldwide to bring new and better treatments to\npatients faster. The second is SoftScan(R), a medical imaging device designed\nto improve the diagnosis and treatment of breast cancer. ART is\ncommercializing its products in a global strategic alliance with\nGE Healthcare, a world leader in mammography and imaging. ART's shares are\nlisted on the TSX under the ticker symbol ARA. Visit ART online at www.art.ca\n\nThis press release may contain forward-looking statements subject to\nrisks and uncertainties that would cause actual events to differ materially\nfrom expectations. These risks and uncertainties are described in ART Advanced\nResearch Technologies Inc.'s regulatory filings with Canadian Securities\nCommissions.\n\n\n","length":2257,"tagName":"div"}]